112 related articles for article (PubMed ID: 10585330)
1. Antithymocyte globulin-induced acute renal failure.
Levine JM; Lien YH
Am J Kidney Dis; 1999 Dec; 34(6):1155. PubMed ID: 10585330
[No Abstract] [Full Text] [Related]
2. Acute renal failure following antithymocyte globulin therapy for aplastic anaemia-report of two cases and review of literature.
Gupta N; Mahapatra M; Rathi S; Kapoor R; Singh A; Seth T; Mishra P
Ann Hematol; 2011 Feb; 90(2):239-41. PubMed ID: 20544349
[No Abstract] [Full Text] [Related]
3. Prolonged renal failure secondary to antithymocyte globulin treatment in severe aplastic anemia.
Barakat RK; Schmolck JP; Finkel KW; Foringer JR
Ann Pharmacother; 2007 May; 41(5):895-8. PubMed ID: 17426071
[TBL] [Abstract][Full Text] [Related]
4. [Curative effect of antithymocyte globulin for aplastic anemia in 8 children].
Zhao XL; DU L; Pan KL
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):760-2. PubMed ID: 21924031
[No Abstract] [Full Text] [Related]
5. Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia.
Killick SB; Marsh JC; Booth JC; Gordon-Smith EC
Bone Marrow Transplant; 1997 Feb; 19(3):249-51. PubMed ID: 9028554
[TBL] [Abstract][Full Text] [Related]
6. Successful desensitization to antithymocyte globulin in a child with aplastic anemia.
Hall M; Hagemann TM
Am J Health Syst Pharm; 2006 Sep; 63(17):1633-6. PubMed ID: 16914633
[No Abstract] [Full Text] [Related]
7. [Moderate aplastic anemia associated with Crohn's disease during antithymocyte globulin treatment].
Mori M; Tanaka T; Akifuji Y; Ueki J; Nakamoto S; Uwai M; Terui Y; Tomizuka H; Hatake K; Ozawa K; Miura Y
Rinsho Ketsueki; 1999 Oct; 40(10):1105-9. PubMed ID: 10565229
[TBL] [Abstract][Full Text] [Related]
8. Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression.
Snow MH; Cannella AC; Stevens RB; Mikuls TR
Arthritis Rheum; 2009 Sep; 61(9):1271-4. PubMed ID: 19714613
[No Abstract] [Full Text] [Related]
9. Antithymocyte globulin induced posterior reversible encephalopathy in aplastic anemia.
Dayama A; Seth T; Mishra P; Mahapatra M
Neurol India; 2013; 61(4):430-1. PubMed ID: 24005743
[No Abstract] [Full Text] [Related]
10. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.
Champlin R; Ho W; Gale RP
N Engl J Med; 1983 Jan; 308(3):113-8. PubMed ID: 6336819
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
[No Abstract] [Full Text] [Related]
12. [Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application].
Kulagin AD; Lisukov IA; Miloserdov IA; Afanas'ev BV
Ter Arkh; 2010; 82(7):65-72. PubMed ID: 20853613
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.
Takabayashi M; Sakai R; Sakamoto H; Iemoto Y; Kanamori H; Inayama Y; Ishigatsubo Y
Anticancer Drugs; 2003 Mar; 14(3):251-3. PubMed ID: 12634621
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report.
Park Y; Chung BH; Park CW; Kim YS; Yang CW
BMC Nephrol; 2020 Jul; 21(1):251. PubMed ID: 32615929
[TBL] [Abstract][Full Text] [Related]
15. Rapid intravenous desensitization to antithymocyte globulin in a patient with aplastic anemia.
Ferdman RM; Wakim M; Church JA; Hofstra TC; Thomas D; Genyk YS
Transplantation; 2004 Jan; 77(2):321-3. PubMed ID: 14743005
[No Abstract] [Full Text] [Related]
16. Serum sickness and severe acute renal failure after rabbit antithymocyte globulin treatment in aplastic anemia: a case report.
da Silva PS; Passos RM; Waisberg DR; Park MV
J Pediatr Hematol Oncol; 2011 Jan; 33(1):43-6. PubMed ID: 21063223
[TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia.
Morishita Y; Matsukawa Y; Kura Y; Takei M; Tomita Y; Nishinarita S; Horie T
J Int Med Res; 1997; 25(4):219-23. PubMed ID: 9283997
[TBL] [Abstract][Full Text] [Related]
18. Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome.
Bevans MF; Shalabi RA
Clin J Oncol Nurs; 2004 Aug; 8(4):377-82. PubMed ID: 15354924
[TBL] [Abstract][Full Text] [Related]
19. Antithymocyte globulin: a realistic approach to therapy for severe aplastic anemia.
Hunter RF; Huang AT
South Med J; 1986 Sep; 79(9):1121-5. PubMed ID: 3529435
[TBL] [Abstract][Full Text] [Related]
20. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
[Next] [New Search]